Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.
first published: Jun 18, 2015 12:33 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell

Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell

Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more

How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
You are already a Moneycontrol Pro user.

